Trial Profile
Clinical protocol for a randomized, double-blind, placebo-controlled study of the efficacy and safety of celecoxib (SC-58635) in the prevention of colorectal sporadic adenomatous polyps.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 May 2011
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Colorectal cancer; Intestinal polyps; Polyps; Sporadic adenomas
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms PRESAP
- Sponsors Pfizer
- 01 Jun 2008 Five-year results from 1043 patients published as an abstract in Gastroenterology.
- 20 Dec 2007 The completion date for this trial is now 1 May 2007.
- 04 May 2007 Status change